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Abstract
Background: Ukraine developed Europe’s most severe HIV epidemic due to widespread transmission among persons who
inject drugs (PWID). Since 2004, prevention has focused on key populations; antiretroviral therapy (ART) coverage has
increased. Recent data show increases in reported HIV cases through 2011, especially attributed to sexual transmission, but
also signs of potential epidemic slowing. We conducted a data triangulation exercise to better analyze available data and
inform program implementation.
Methods and Findings: We reviewed data for 2005 to 2012 from multiple sources, primarily national HIV case reporting and
integrated biobehavioral surveillance (IBBS) studies among key populations. Annually reported HIV cases increased at a
progressively slower rate through 2011 with recent increases only among older, more immunosuppressed individuals; cases
decreased 2.7% in 2012. Among women ,25 years of age, cases attributed to heterosexual transmission and HIV prevalence
in antenatal screening declined after 2008. Reported cases among young PWID declined by three-fourths. In 2011,
integrated biobehavioral surveillance demonstrated decreased HIV prevalence among young members of key populations
compared with 2009. HIV infection among female sex workers (FSW) remains strongly associated with a personal history of
injecting drug use (IDU).
Conclusions: This analysis suggests that Ukraine’s HIV epidemic has slowed, with decreasing reported cases and older cases
predominating among those diagnosed. Recent decreases in cases and in prevalence support decreased incidence among
young PWID and women. Trends among heterosexual men and men who have sex with men (MSM) are less clear; further
study and enhanced MSM prevention are needed. FSW appear to have stable prevalence with risk strongly associated with
IDU. Current trends suggest the Ukrainian epidemic can be contained with enhanced prevention among key populations
and increased treatment access.
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With the explosive growth of HIV transmission among persons
who inject drugs (PWID) in Ukraine beginning in 1995, a wave of
HIV infection spread across the former Soviet Union [1]. With
continued increases in cases among PWID and, to a lesser degree,
other key populations (KP), Ukraine developed the most severe
epidemic in Europe and Central Asia with an estimated 440,000
persons living with HIV (PLHIV) in 2007 [2]. Prevention and care
responses began with spontaneous local efforts supported by
limited local and state budgets and uncoordinated external grants.
Beginning in 2004, coordinated external support from the Global
Fund, US government, and others allowed a major expansion of
prevention programs focused on KP and antiretroviral therapy
(ART). In 2011, the number of PWID reached with prevention
activities was 160,000 as compared to 54,000 in 2006, while the
number of PLHIV on ART increased from 255 in 2004 to.6,000
in 2008 [3]. Since 2008, the government of Ukraine has assumed
principal responsibility for ART, which, as of January 2014,
reached.55,000 [4] of the estimated 100,000 PLWHA in need of
ART [5].
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In recent years, available reported data have produced
conflicting interpretations of the evolution of the Ukrainian
epidemic. While HIV cases among PWID dominated the first
decade, heterosexual transmission has been the predominant
attributed route of transmission among newly registered HIV cases
since 2008 [6]. Annual numbers of newly reported cases
progressively increased from 2000 through 2011, although the
rate of increase slowed after 2006. The annual number of HIV-
positive pregnant women continued to increase through 2011
although HIV prevalence in screening of pregnant women not
previously registered as HIV-infected declined after 2009 [6]. To
improve the understanding of these changes and better guide the
response, we carried out a data triangulation analysis of available
HIV surveillance and programmatic data sources for the period
2005–2012. The focus for the analysis reported here was to clarify
current patterns of HIV transmission in Ukraine.
Methods
Ethics statement
All surveys whose data were included in the analysis had
received national institutional review board approval from the
Committee on Medical Ethics of the Gromachevsky Institute of
Epidemiology and Infectious Diseases and from the Committee of
Professional Ethics of the Ukrainian Sociological Society. Case
reporting systems are established by Ukrainian law. The analysis
was reviewed at the University of California, San Francisco
Committee on Human Research and received an exemption due
to the lack of access to individual level data.
Data sources
Triangulation is an analytical approach that compares and
interprets multiple data sources to improve the understanding of a
public health problem and assess the impact of population-level
interventions [7]. Diverse data sources help reduce the random
and systematic errors often present in single surveillance and
programmatic data sets.
We conducted a secondary analysis of data sources that
included HIV case reports, HIV prevalence proxy indicators from
antenatal clinic (ANC) and military recruit screening, and HIV
prevalence data from integrated biological and behavioral surveys
(IBBS) among KP including PWID, female sex workers (FSW) and
men who have sex with men (MSM). We also reviewed general
population demographic and birth data from the Ukrainian State
Statistics Service. No individual level data were reviewed in our
analysis; we obtained and analyzed the summary data for these
indicators from two sources: 1) for HIV case reports and HIV
screening of pregnant women and military recruits, from the
Ukrainian Center for Socially Dangerous Disease Control, which
houses the national HIV case reporting surveillance system data;
and 2) for IBBS surveys, from the International HIV/AIDS
Alliance in Ukraine, which coordinates the Global Fund supported
national IBBS surveys. Access to this summary data for other
researchers is potentially available subject to approval of requests
by the respective institutions.
HIV and AIDS case reports
In Ukraine, population HIV antibody screening, including high
coverage screening of pregnant women, has been carried out since
1987. After a positive screening result, individuals are referred to a
network of government AIDS centers. These centers are the only
providers of HIV care and treatment, which is provided without
charge to individuals whose HIV infections are confirmed on
supplemental testing; registration is mandatory to receive care.
Individual-based data are reported mandatorily for all patients
registered in the network; we analyzed summary data reports and
restricted our analysis to cases among individuals$15 years of age.
When HIV-infected individuals are registered at AIDS centers, the
severity of HIV illness is classified according to a clinical scale
based on WHO guidelines [8]. The categories can be grouped into
WHO clinical stage I (asymptomatic and persistent generalized
lymphadenopathy), clinical stages 2 and 3 symptomatic (mild and
advanced), and clinical stage 4 (AIDS-defining conditions). In
2010, newly registered cases with pulmonary TB were no longer
classified as stage 3 but were assigned to stage 4. For our analysis,
we combined stages 2–4 (symptomatic and AIDS cases) as
‘advanced immunodeficiency’ and compared with stage 1
(‘asymptomatic’). We calculated median ages assuming that cases
were evenly distributed in the five- or 10-year age-groups in which
they were reported.
Ukraine has 27 administrative subdivisions, including 24
oblasts, Kyiv City, Sebastopol City, and the Autonomous Republic
of Crimea; we refer to these generically as regions. We constructed
terciles of regions by dividing regions into three groups based on
the average annual number of the newly reported HIV cases per
100,000 total population over the period from 2005 to 2012. We
refer to these as ‘new case report’ terciles, with the acknowledg-
ment that newly reported cases are not equivalent to newly
transmitted cases.
ANC screening and reported data
All pregnant women not already registered as HIV-positive are
provided routine opt-out HIV testing in ANC; screening includes
rapid testing for women who present at delivery without antenatal
care. HIV status has been identified for.95% of delivering
mothers since 2003 and.99% since 2007 (excluding 97.2% in
2010 [6]). Pregnant women who are found to be HIV-infected in
ANC screening are registered with AIDS centers where free care
and treatment, including antiretrovirals for prevention of mother-
to-child transmission (PMTCT), are available. Two types of data
were analyzed on HIV prevalence among pregnant women. First,
summary data are reported on HIV screening in ANC, which
excludes women registered as HIV-infected prior to their
pregnancy. Testing twice in pregnancy is recommended. Prior to
2007, only the summary result of all screening HIV tests done in
pregnancy was reported; since 2007, data have been reported
separately on HIV prevalence at the initial test in pregnancy.
Second, summary data are reported on the number of HIV-
exposed infants; the mothers of these infants will include both
women registered as HIV-infected prior to pregnancy and those
identified in ANC. We used the proportion of HIV-exposed births
among all births as a proxy for HIV prevalence among delivering
mothers.
IBBS data
Since 2004, IBBS have been conducted by the International
HIV/AIDS Alliance in Ukraine, with progressively increasing
coverage of KP. All regions were covered for PWID and FSW in
the rounds conducted in 2008–2009 (hereafter 2009 round) and
2011, and near-national coverage was first achieved among MSM
in 2011. In the 2011 IBBS studies, investigators also estimated
hepatitis C (HCV) prevalence, using a combination rapid test for
HIV/HCV.
Statistical analysis
To evaluate trends in reported HIV cases with asymptomatic
HIV infection at presentation, among women 15–24 years of age,
and among men entering military service, we performed Poisson
Slowing of the HIV Epidemic in Ukraine: 2005–2012
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regression analysis [9] using SAS software [10]. To evaluate trends
in HIV prevalence among pregnant women for 2007–2009 and
2010–2012, we used a linear spline Poisson regression model to
estimate separate regression lines and perform tests for trends [11].
To compare the proportion of cases with advanced immunode-
ficiency at presentation between selected years we used Pearson’s
chi-squared test and to compare HIV seroprevalence in the 2011
FSW survey between FSW subgroups we used Mantel-Haenszel
odds ratios. Other statistics reported for survey data are taken
from the published reports.
Results
From the beginning of case reporting in 1987 until the end of
2012, 186,821 cases of HIV in adults and adolescents$15 years of
age had been reported; from 2005 through 2012, 120,351 cases
were reported (Figure 1) of which 57.3% were male. The annual
rate of increase in reported cases slowed from 10.3% annually in
2005 to 4.4% in 2011; cases then fell by 2.7% in 2012. Reported
cases had a median age of 25.9 years in 1995; median age
progressively increased from 2005 to 2012 among both men (32.1
to 36.3 years) and women (27.9 to 33.3 years). In recent years, the
absolute number of cases reported among individuals ,30 years of
age has declined both among males (2,993 cases in 2006 to 1,826
in 2012, 239%) and females (3,489 cases in 2008 to 2,781 in 2012,
220%). Since 2007, cases attributed to heterosexual transmission
have progressively exceeded those attributed to IDU (Figure 2a).
The proportion of newly reported adult cases with advanced
immunodeficiency at presentation increased sharply from 37.7%
in 2005 to 53.0% in 2012 (P,0.01); the absolute number of
reported cases with asymptomatic HIV infection at presentation
declined by 19.2% from 2009 to 2012 (P,0.01) (Figure 2b).
Reported cases remained highly concentrated in eastern and
southeastern regions in 2005–2012 as in previous years
(Figure 3). The nine regions in the top new case report tercile
for all cases contributed 70.1% of HIV cases reported over this
period but contained only 40.8% of the population; seven of these
regions were in the south and southeast and contributed 61.8% of
cases but only 32.3% of the population.
Trends in reported cases and prevalence among PWID
From 2005–2012, 54,053 (44.9%) newly reported cases of HIV
were attributed to injection drug use (IDU), and, of these, 80%
were male. Among individuals ,25 years of age, 4,884 HIV cases
were attributed to IDU. Nationwide, the number of annually
reported cases among PWIDs,25 years of age fell by 78% from
2005 to 2012 (Figure 4a).
Overall HIV prevalence among PWID as measured in IBBS
remained unchanged at 21.6% between 2009 and 2011. Among
PWID,25 years old, HIV prevalence declined from 9.9% to
7.2% overall (P = 0.01), with declines in almost all regions with
higher incidence among PWID (Figure 4b)[12–14].
Figure 1. Reported HIV cases among adults and adolescents, Ukraine 1995–2012.
doi:10.1371/journal.pone.0103657.g001
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Trends in reported HIV cases attributed to heterosexual
transmission
From 2005–2012, 63,177 cases of HIV were attributed to
heterosexual intercourse, and of these 62% were women and 38%
men.
Women. The number of annually reported cases attributed to
sexual transmission in women $25 years old more than doubled
from 1,814 cases in 2005 to 5,057 cases in 2012. Among younger
women, HIV cases attributed to heterosexual transmission peaked
in 2008 with 297 cases (1.9 cases per 10,000 population) among
15–19 year olds and 1,226 cases (6.4 cases per 10,000) among
20–24 year olds; in 2012, 177 cases (1.4 cases per 10,000) were
reported among 15–19 year olds and 910 cases (5.5 cases per
10,000) among 20–24 year olds, representing 24.4% (p,.01) and
14.7% (p,0.001) declines in the rates of reported cases in the
respective age groups. The largest declines in heterosexual cases in
women ,25 years old were in the nine regions with the highest
incidence of reported HIV cases among PWID, with declines of
40% in Donetsk and Mykolaiv oblasts and 65% in Kyiv City.
Men. From 2005 to 2012, the annual number of adult and
adolescent cases attributed to sexual transmission increased by ,
1% among men ,25 years old but increased by 202% among men
$25 years old. A 2008–2009 study surveyed newly registered male
HIV cases attributed to heterosexual transmission and found that
8.5% reported a history of personal IDU and 17.3% reported
PWID sexual partners; reviews of case records found that 27% had
HCV antibodies. The study did not report on the overlap between
antibody status and reported risk factors [15].
Trends among pregnant women
HIV prevalence among all women who delivered rose
progressively from 0.59% in 2005 to 0.81% in 2010 (6.2% per
year, 95% CI: 5.4% to 7.1 %) and then stabilized, being 0.78% in
2012 (21.7% per year, 95% CI: 23.6% to 0.1%, from 2010 to
2012); the trends in these two periods were significantly different
(p,0.01) (Figure 5). The overall HIV prevalence found in initial
ANC screening of pregnant women who were not previously
registered as HIV-infected rose from 0.52% in 2007 to 0.55% in
2009 (1.6% per year, 95% CI: 20.7% to 3.9%), and then
decreased to 0.45% in 2012 (26.8% per year, 95% CI: 28.3% to
25.4%); the trends in these two periods were significantly different
(p,0.01). HIV prevalence in initial ANC screening correlated
with incidence among PWID; median prevalence was 0.73% in
the PWID cumulative case-report top tercile of regions, 0.25% in
the middle tercile, and 0.12% in the low tercile. A survey among
839 HIV-infected women detected in ANC from 2009 to 2011
found that 6.6% reported personal histories of IDU while 24.8%
reported a PWID partner [15].
HIV prevalence in men entering military service
Universal HIV screening of male conscripts began in 2008. As
of 2012, 340,405 men had been screened, and 284 (0.08%) were
found to be HIV-infected. There has been a gradual decline in
prevalence among male conscripts over this period, from 0.11% in
2008 to 0.07% in 2012, a decline of 13.7% per year (95% CI:
4.8%–21.7%). In a 2007 survey of conscripts, 1.5% reported
having ever injected drugs and 0.4% had injected in the last month
[16].
HIV prevalence in FSW and clients of FSW
In the 2011 IBBS, an estimated 9.0% of FSW were infected
with HIV, compared to 12.9% in 2009 [17–18]. Among FSW 14–
24 years old, the prevalence declined from 8.3% to 3.6%; both
declines were statistically significant (p,0.01) [18]. HIV preva-
lence among FSW was generally higher in the highest PWID
tercile oblasts (Table 1) and infection status among FSW was
associated with a personal history of IDU. In the 2011 survey,
overall HIV prevalence among FSW was 41.1% among those who
reported having injected drugs in the last 12 months, 31.3%
among those who reported injecting but not within 12 months,
and 6.0% among those who denied ever using drugs (p,0.01 for
all comparisons [18]). Among FSW who denied drug use but who
Figure 2. Newly reported HIV cases, Ukraine 2005–2012. a.
Attributed route of transmission. b. Clinical status at time of
presentation.
doi:10.1371/journal.pone.0103657.g002
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were HCV-antibody positive, HIV prevalence was 30.3%. Of
1,117 FSW who either admitted to drug use or were HCV-
seropositive, 346 (31.1%) were seropositive compared with 156
(4.1%) of 3,846 HCV-antibody negative FSW who denied drug
use (odds ratio 10.7; 95% CI 8.7–13.1).
A survey of clients of FSW in 2009 showed an overall
prevalence of 7.4%. The prevalence was 23% among clients
admitting previous IDU and 3% among those clients denying IDU
[19].
HIV in MSM
Only 645 cases from 2005–2012 were attributed to male-to-
male sexual transmission. The 2009 and 2011 IBBS found an
overall HIV prevalence of 8.6% and 6.4%, respectively among all
MSM nationwide and 7.4% and 4.2% respectively among MSM,
25 years of age [20–21].
Discussion
Although UNAIDS had previously included Ukraine as part of
the growing Eastern Europe and Central Asia HIV epidemic [22],
the 2013 UNAIDS Global Report indicates there are an estimated
230,000 PLHIV in 2013 and that modeled incidence has declined
68% from 2001 to 2012 in Ukraine [5]. The marked decline in
prevalence from the 2007 estimate [2] reflects improved data for
modeling as well as the impact of decreased incidence and
substantial mortality. Our study also indicates that the epidemic
among PWID in Ukraine is declining, that the female heterosexual
epidemic linked to the PWID epidemic [23] may have peaked, and
that the available evidence suggests a declining incidence in recent
years. The case reporting data show that overall cases have begun
to decline in 2012 while older, more clinically advanced patients
are responsible for all of the increase in cases seen from 2005 to
2011. The increasing age and immunodeficiency at presentation of
these cases almost certainly reflect the detection of patients who
were infected long ago and who presented due to clinical need.
The progressive decline in new HIV cases with asymptomatic
illness since 2009 suggests a decline in the number of undiagnosed
individuals in earlier stages of illness.
The declines in both reported cases and HIV prevalence among
young PWID in IBBS also support a decrease in transmission
among PWID. The plateauing and subsequent modest decline in
HIV cases among all PWID since 2005 and the recent decline in
overall cases suggests that a majority of the individuals infected in
the early large wave of epidemic spread from 1995–1998 have
either been diagnosed (and registered) or died. Mortality analyses
show a disproportionate mortality burden among PWID, with late
Figure 3. Average annual number of reported HIV cases per 100,000 population, by region, Ukraine 2005–2012.
doi:10.1371/journal.pone.0103657.g003
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Figure 4. HIV surveillance among IDU,25 years of age, Ukraine. a. Reported HIV cases by sex, 2005–2012. b. HIV prevalence in IBBS by
region: 2008/2009 and 2011.
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presentation and inadequate access to ART as contributing factors
[24].
The overall number of HIV-infected PWID remains high, and
this predominantly male group continues to be a major source for
new heterosexual infections, especially in female partners. This is
supported by the higher prevalence among women in regions with
higher HIV prevalence among PWID and by the large proportion
of HIV-infected women newly detected in ANC screening who,
despite considerable stigma, report IDU as a risk factor in their
partners.
The decline in reported HIV cases among women younger than
25 years may suggest that heterosexual transmission has begun to
decline. Screening of pregnant women has also shown a decline in
the prevalence of newly detected HIV infections. The pregnancy
screening indicator in Ukraine is likely to be affected quickly by
changes in incidence in the underlying population of women, since
previously registered HIV cases are excluded, screening in
pregnancy is essentially universal among women preventing for
ANC care, and because the low coverage of hormonal contra-
ception [25] should result in a high rate of pregnancy among
women acquiring HIV heterosexually. We postulate that the
decline in cases among young women is causally related to
declining transmission from infected PWID to their partners.
The survey data clearly show the strong relationship between
IDU and increased risk of HIV in both FSW (by history and by
HCV antibody status) and their clients (by history) in Ukraine.
The true contribution of IDU to HIV infection in these groups is
likely underestimated due to self-underreporting of IDU. Even
with the use of HCV status to indicate a history of IDU, not all
PWID will be identified, since not all are HCV seropositive. In the
2011 IBBS, only 61% of HIV-infected female FSW who admitted
IDU were HCV seropositive, so the HIV seroprevalence among
FSW who have truly never injected is almost certainly less than the
4% observed among those who denied injecting and who were
HCV seronegative. These data from FSW and conscripts that
indicate much of the observed HIV prevalence in both groups
could be accounted for by IDU, suggest limited HIV transmission
that is not linked to IDU in these groups.
In contrast, reported cases among men attributed to heterosex-
ual transmission have risen sharply, primarily among those older
than 30 years. We believe that misclassification contributes
significantly due to the stigma associated with IDU and MSM
behavior. The history and hepatitis C antibody status of the male
‘heterosexual’ cases reviewed demonstrated that .25% had
evidence of personal or sex partner IDU behavior. Other historical
evidence of misclassification of male cases due to IDU includes
data from the case-reporting system from 1995–1996, showing
that among the 5,004 adult male cases reported, 752 cases were
attributed to ‘heterosexual’ transmission and 276 to ‘other’ causes.
During this period of initial intense IDU transmission, only
infrequent instances of heterosexual transmission to males would
have occurred. Presumably, this misclassification by the registering
physicians reflected less obvious IDU behavior among these
individuals; individuals with less intense IDU behavior would also
be likely to have decreased contact with the HIV screening sites
that access males, which are primarily in drug treatment, prison,
and clinical facilities. A greater proportion of these ‘misclassifiable’
IDU cases might therefore be detected only later with onset of
Figure 5. HIV prevalence among pregnant women at initial antenatal screening and at delivery, Ukraine 1995–2012.
doi:10.1371/journal.pone.0103657.g005
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clinical symptoms; such cases may be contributing to the increase
in recent years in newly reported older ‘heterosexual’ cases with
advanced immunodeficiency. Additionally, significant misclassifi-
cation of MSM in case reporting is supported by the contrast
between low numbers of reported cases among MSM and the
MSM IBBS prevalence data [26].
There are several limitations in interpreting the data analyzed
here. All HIV case reporting systems are dependent on case
presentation, detection, registration, and reporting; collection of
risk factor data in these systems varies greatly. In Ukraine, the case
reporting is facilitated by a centralized system of HIV care and
reporting functioning since 1987 with only limited changes. The
dominance of government health care and the existence of severe
administrative penalties for nonreporting also reinforce complete
reporting; epidemiologists from the Ukrainian Center for Socially
Dangerous Disease Control who monitor AIDS Centers’ surveil-
lance functions consider reporting of cases to be highly complete.
However, risk behavior data are limited to presumed mode of
transmission. Even these data are either underreported (PWID,
MSM) or not collected (FSW) and analysis has not routinely
triangulated data from other studies where more behavioral data
were available. HIV screening and confirmation is limited to state-
certified laboratories and these data are also reported in a
standardized fashion. Assessments by UNAIDS of the Ukrainian
case reporting surveillance system [27] and the similar Russian
system [28] support these strengths and limitations. Another
limitation is that ANC screening, although extremely high among
pregnant women presenting for antenatal care has been incom-
plete (50%–60%) for women presenting for therapeutic abortion
during this period; these women represented 21.4% of all
pregnancies in 2012. However, the progressive and highly
significant decline in both relative and absolute number of HIV-
positive women found in screening from 2008–2012 suggests that
random fluctuation in testing among the unscreened minority of
women presenting for abortion is unlikely to be responsible. In
addition to these general limitations, the population screening and
case reporting system in Ukraine is likely to detect HIV cases
earlier among women than men, as a significant proportion of
women infected heterosexually will be detected soon after infection
given the low prevalence of hormonal contraception and near-
universal ANC screening of pregnant women presenting for
antenatal care. The lack of comparable screening access to men
means that a higher proportion of infected men will be detected
later in their disease. Another limitation of routine data is the
inability to differentiate whether women with heterosexually
acquired HIV were infected by PWID or by non-PWID partners.
In addition, comparisons of numbers of case reports from younger
age cohorts are becoming more complicated by the aging into
adulthood of birth cohorts born after 1991, when an unprece-
dented decline in births followed the breakup of the Soviet Union
[29]. However, the observed declines in cases among young
females exceed the declines in population, resulting in significantly
lower rates of reported cases. Also, the declines in HIV prevalence
measured in ANC screening and in IBBS among key populations
would not be affected by declining population size and provide
independent support for our finding of a decline in HIV among
younger age groups. While IBBS surveillance data from the earlier
rounds are limited by lack of consistent coverage of all regions and
by variation in methodology for FSW studies, the prevalence
declines are also found in the 2009 and 2011 rounds, which used
comparable methodology and achieved national coverage for
PWID and FSW.
Modifications of HIV surveillance in Ukraine are needed to

































































































































































































































































































































































































































































































Slowing of the HIV Epidemic in Ukraine: 2005–2012
PLOS ONE | www.plosone.org 9 September 2014 | Volume 9 | Issue 9 | e103657
to elucidate the risk status of partners of newly reported female
cases, especially among younger women, would help in tracking
further evolution of the epidemic, as would studies to better
identify risk behavior histories for reported male heterosexual
cases. Additional studies to explore sexual mixing patterns among
PWID and non-drug-injecting heterosexual ‘‘bridge populations’
would also be useful [23]. Finally, new assays for recent HIV
infection, such as the limiting antigen assay [30], should be
incorporated into surveillance activities to characterize risk factors
for recent infection and more accurately track incidence in risk
groups.
From the programmatic viewpoint, enhancing prevention
among KP remains the highest priority. Given the continuing
critical role of IDU, further scale up of coverage with needle and
syringe exchange programs, opioid substitution therapy [31], and
ART for HIV-infected PWID at earlier stages of infection should
be priorities. Given high HIV prevalence among FSW, earlier
identification and treatment of HIV-infected FSW may offer an
opportunity to further limit heterosexual transmission. The
persistent risk behavior and limited coverage of prevention
programs among MSM [21] raise concerns about expansion of
this epidemic, and increased prevention efforts are needed.
Expanded and enhanced prevention efforts, including identifica-
tion of discordant couples and increased ART, could help limit
transmission between infected PWID (and former PWID) and
their partners and help address a major source of infection for
young women [32].
Increased efforts in Ukraine to enhance prevention and
treatment among KP are still needed, combined with strong
advocacy to enhance government support of prevention programs
and decrease dependency on external funding. Thesemeasures
could limit further growth in the Ukrainian epidemic but will be
extremely challenging in the short term, given recent decreases in
Global Fund resources for Ukraine and the severe strain on
government resources due to the ongoing armed conflict in
Eastern Ukraine. However, Ukraine’s success in expanding
prevention coverage among KP and the evidence of significant
improvements in the epidemic to date stand in contrast to the
situation in the Russian Federation where ‘Western’-style harm
reduction efforts are not prioritized [33], reported cases are
accelerating [34], and the WHO/UNAIDS estimate exceeds
900,000 PLHIV in 2013 [5]. These trends support the effective-
ness of prevention programs among KP in Eastern Europe and
suggest that Ukraine may no longer have the most severe HIV
epidemic in Europe.
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